Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96
Clinical trial NCT04589728 · COMPLETED
Trial details
- NCT number
- NCT04589728
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-23
- Primary completion
- 2024-09-08
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.